A comprehensive analysis of nearly 50,000 eye patients in England found a striking disparity: people living in more economically deprived areas achieved significantly worse vision outcomes after treatment for neovascular age-related macular degeneration (NvAMD), even when they received the same number of injections as wealthier patients. The study, which examined data from the Royal College of Ophthalmologists National Ophthalmology Database, suggests that socioeconomic factors beyond medical treatment itself play a crucial role in eye health outcomes .

What Is Neovascular Age-Related Macular Degeneration?

NvAMD is an advanced form of age-related macular degeneration, a progressive eye condition that damages the macula, the part of the retina responsible for sharp central vision. This condition is the leading cause of irreversible vision loss in older adults in developed countries, affecting an estimated 200 million people worldwide. When NvAMD develops, abnormal blood vessels grow under the retina and can cause rapid central vision loss if not treated promptly .

The standard treatment involves regular injections of anti-VEGF medications, which block vascular endothelial growth factor, a protein that promotes abnormal blood vessel growth. Early diagnosis and treatment with these injections significantly improve vision outcomes, making timely intervention critical .

How Did Deprivation Affect Treatment Outcomes?

Researchers analyzed data from 48,583 eyes treated at 60 English centers between April 2020 and March 2023. They compared outcomes across deprivation levels using the English Indices of Multiple Deprivation, which ranks neighborhoods based on income, employment, education, health, crime, housing, and living environment. The findings revealed consistent disparities across multiple measures .

Patients in the most deprived areas started treatment at a younger median age of 79 years, compared to 82 years in the least deprived areas. However, this younger age at treatment onset did not translate to better outcomes. Instead, patients from more deprived neighborhoods had lower baseline vision before treatment began and experienced worse results after one year of care .

The vision outcome gaps were substantial. Among patients in the least deprived areas, 45.5% achieved a "good" vision outcome, defined as 70 or better on the standard eye chart measurement. In contrast, only 35.9% of patients in the most deprived areas reached this threshold. Conversely, poor outcomes, defined as losing 10 or more letters of vision from baseline, occurred in 18.4% of patients from the most deprived areas compared to 14.5% in the least deprived areas .

Loss to follow-up also differed by deprivation level. Approximately 13.7% of patients in the most deprived areas did not complete their one-year follow-up appointments, compared to 11.8% in the least deprived areas. This gap suggests that barriers to consistent care may be contributing to worse outcomes .

Why Are These Disparities Occurring Despite Equal Treatment?

The study found little variation in the actual medical treatment delivered across deprivation levels. Patients received similar numbers of injections, ranging from 7 to 8 injections during the first year regardless of where they lived. This suggests that the disparities in vision outcomes are not due to differences in the amount of medication administered .

Instead, the gaps likely reflect broader barriers to optimal eye care. Patients in more deprived areas may face challenges accessing appointments, affording transportation to clinics, managing multiple health conditions, or receiving adequate support between treatments. Additionally, patients starting treatment at younger ages in deprived areas may indicate that their disease progressed further before diagnosis, meaning they had more advanced vision loss at the start of treatment. Since baseline vision is one of the strongest predictors of long-term outcomes, starting from a lower vision level makes it harder to achieve good results .

Steps to Protect Your Vision and Ensure Quality Eye Care

Schedule regular eye exams: Early detection of macular degeneration and other eye diseases significantly improves treatment outcomes. Adults over 50 should have comprehensive eye exams at least every one to two years, or more frequently if recommended by their eye doctor.
Attend all scheduled appointments: Consistency in treatment is essential for managing NvAMD. Missing appointments can delay necessary injections and reduce the effectiveness of therapy, so prioritize attending every scheduled visit even if it requires arranging transportation or taking time off work.
Communicate with your eye care team: If you face barriers to attending appointments, such as transportation difficulties or financial constraints, discuss these challenges with your ophthalmologist or clinic staff. Many centers offer resources, payment plans, or referrals to community services that can help.
Maintain overall health: Managing conditions like diabetes, which was present in 12.7% of the study population, can help protect your vision and improve treatment outcomes for eye diseases.

What Does This Mean for Eye Health Equity?

This research highlights an important gap in eye health equity within the National Health Service (NHS) in England. While the healthcare system provides free treatment to all patients, the outcomes are not equal. The study demonstrates that inequality in eye health is increasingly being identified across the conditions most responsible for visual impairment, with socioeconomic deprivation associated with more advanced eye disease at diagnosis and lower uptake of optometry services .

The findings suggest that simply providing equal access to treatment is not enough. Healthcare systems and policymakers may need to address underlying social and economic factors that prevent patients in deprived areas from achieving the same vision outcomes as wealthier patients. This could include improving transportation services, offering flexible appointment times, providing financial support, or implementing community outreach programs to encourage earlier diagnosis .

For patients concerned about their eye health, the key takeaway is clear: do not delay seeking care if you notice changes in your vision, and work closely with your eye care team to ensure you receive timely treatment. Your location and circumstances should not determine your vision outcomes, and advocating for yourself within the healthcare system is an important step toward protecting your sight.

" }